BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 31775230)

  • 21. THC and CBD: Villain versus Hero? Insights into Adolescent Exposure.
    Pintori N; Caria F; De Luca MA; Miliano C
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.
    Nadulski T; Pragst F; Weinberg G; Roser P; Schnelle M; Fronk EM; Stadelmann AM
    Ther Drug Monit; 2005 Dec; 27(6):799-810. PubMed ID: 16306858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mid-infrared spectroscopy as process analytical technology tool for estimation of THC and CBD content in Cannabis flowers and extracts.
    Geskovski N; Stefkov G; Gigopulu O; Stefov S; Huck CW; Makreski P
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 Apr; 251():119422. PubMed ID: 33477086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities.
    Lal S; Shekher A; Puneet ; Narula AS; Abrahamse H; Gupta SC
    Pharmacol Res; 2021 Jan; 163():105302. PubMed ID: 33246167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabidiol as potential anticancer drug.
    Massi P; Solinas M; Cinquina V; Parolaro D
    Br J Clin Pharmacol; 2013 Feb; 75(2):303-12. PubMed ID: 22506672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.
    Drugs R D; 2003; 4(5):306-9. PubMed ID: 12952500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders.
    Scuderi C; Filippis DD; Iuvone T; Blasio A; Steardo A; Esposito G
    Phytother Res; 2009 May; 23(5):597-602. PubMed ID: 18844286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging challenges in the extraction, analysis and bioanalysis of cannabidiol and related compounds.
    Brighenti V; Protti M; Anceschi L; Zanardi C; Mercolini L; Pellati F
    J Pharm Biomed Anal; 2021 Jan; 192():113633. PubMed ID: 33039911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Cytochrome P450-Mediated Cannabinoid-Drug Interactions in Healthy Adult Participants.
    Bansal S; Zamarripa CA; Spindle TR; Weerts EM; Thummel KE; Vandrey R; Paine MF; Unadkat JD
    Clin Pharmacol Ther; 2023 Sep; 114(3):693-703. PubMed ID: 37313955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic review of the antipsychotic properties of cannabidiol in humans.
    Iseger TA; Bossong MG
    Schizophr Res; 2015 Mar; 162(1-3):153-61. PubMed ID: 25667194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action.
    Ożarowski M; Karpiński TM; Zielińska A; Souto EB; Wielgus K
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919010
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Canseco-Alba A; Rodríguez-Manzo G
    Rev Invest Clin; 2023; 75(3):105-128. PubMed ID: 37441766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial.
    Grimison P; Mersiades A; Kirby A; Lintzeris N; Morton R; Haber P; Olver I; Walsh A; McGregor I; Cheung Y; Tognela A; Hahn C; Briscoe K; Aghmesheh M; Fox P; Abdi E; Clarke S; Della-Fiorentina S; Shannon J; Gedye C; Begbie S; Simes J; Stockler M
    Ann Oncol; 2020 Nov; 31(11):1553-1560. PubMed ID: 32801017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In search of preventive strategies: novel high-CBD
    Wang B; Kovalchuk A; Li D; Rodriguez-Juarez R; Ilnytskyy Y; Kovalchuk I; Kovalchuk O
    Aging (Albany NY); 2020 Nov; 12(22):22425-22444. PubMed ID: 33221759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study.
    Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC
    J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):561-570. PubMed ID: 34412109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Industrial, CBD, and Wild Hemp: How Different Are Their Essential Oil Profile and Antimicrobial Activity?
    Zheljazkov VD; Sikora V; Dincheva I; Kačániová M; Astatkie T; Semerdjieva IB; Latkovic D
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33053634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine.
    Russo EB; Guy GW; Robson PJ
    Chem Biodivers; 2007 Aug; 4(8):1729-43. PubMed ID: 17712817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical use of cannabis. Cannabidiol: a new light for schizophrenia?
    Deiana S
    Drug Test Anal; 2013 Jan; 5(1):46-51. PubMed ID: 23109356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.